PaulRWestDO

PubMed

• 72 citations
  Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder
  Alan M. Smith, Joseph J. King, Paul R. West, Michael Ludwig, Elizabeth L.R. Donley, Robert E. Burrier, David G. Amaral> ;Biological Psychiatry. 2019 Feb 15
• 96 citations
  Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children.
  Paul R. West, David G. Amaral, Preeti Bais, Alan M. Smith, Laura A. Egnash, Mark E. Ross, Jessica A. Palmer, Burr R. Fontaine, Kevin R. Conard, Blythe A. Corbett, Gabr...> ;Plos One. 2014 Nov 7
• 52 citations
  Establishment and Assessment of a New Human Embryonic Stem Cell‐Based Biomarker Assay for Developmental Toxicity Screening
  Jessica A. Palmer, Alan M. Smith, Laura A. Egnash, Kevin R. Conard, Paul R. West, Robert E. Burrier, Elizabeth L.R. Donley, Fred R. Kirchner> ;Birth Defects Research. Part B, Developmental and Reproductive Toxicology. 2013 Aug 1
• 17 citations
  Metabolic biomarkers of prenatal alcohol exposure in human embryonic stem cell-derived neural lineages.
  Jessica A. Palmer, Ashley M. Poenitzsch, Susan M. Smith, Kevin R. Conard, Paul R. West, Gabriela G. Cezar> ;Alcoholism, Clinical and Experimental Research. 2012 Aug 1
• 67 citations
  Identifying developmental toxicity pathways for a subset of ToxCast chemicals using human embryonic stem cells and metabolomics.
  Nicole Kleinstreuer, Andrew Smith, Paul R. West, Kevin R. Conard, Burr R. Fontaine, A.M. Weir-Hauptman, Jessica A. Palmer, Thomas B. Knudsen, David J. Dix, Elizabeth L...> ;Toxicology and Applied Pharmacology. 2011 Nov 15
• 117 citations
  Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics.
  Paul R. West, April M. Weir, Alan M. Smith, Elizabeth L.R. Donley, Gabriela G. Cezar> ;Toxicology and Applied Pharmacology. 2010 Aug 15
• Join now to see all